Immunome, Inc. (IMNM)
21.84
-0.61
(-2.72%)
USD |
NASDAQ |
Apr 02, 16:00
21.95
+0.11
(+0.50%)
After-Hours: 20:00
Immunome EPS Diluted (Quarterly) : -0.7516 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 1.699 |
| Scholar Rock Holding Corp. | -0.8824 |
| Stoke Therapeutics, Inc. | -0.9922 |
| Nurix Therapeutics, Inc. | -0.8226 |
| CytomX Therapeutics, Inc. | -0.1734 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -69.90M |
| Total Expenses (Quarterly) | 69.90M |
| Enterprise Value | 1.821B |
| Earnings Yield | -11.12% |
| Normalized Earnings Yield | -10.77 |